ASX - By Stock
|
CPH |
Re:
Ann: Creso Pharma completes US OTC dual listing
|
|
NBerardis
|
226 |
63K |
11 |
12/06/21 |
12/06/21 |
ASX - By Stock
|
226
|
63K
|
11
|
|
ASX - By Stock
|
M4M |
Re:
Bankable Feasibility Study Schedule
|
|
NBerardis
|
235 |
73K |
3 |
17/05/21 |
17/05/21 |
ASX - By Stock
|
235
|
73K
|
3
|
|
ASX - By Stock
|
M4M |
Re:
Bankable Feasibility Study Schedule
|
|
NBerardis
|
235 |
73K |
4 |
17/05/21 |
17/05/21 |
ASX - By Stock
|
235
|
73K
|
4
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Mernova Awarded Craft Designation with OCS
|
|
NBerardis
|
128 |
32K |
0 |
17/05/21 |
17/05/21 |
ASX - By Stock
|
128
|
32K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Pause in Trading
|
|
NBerardis
|
20 |
9.4K |
1 |
12/05/21 |
12/05/21 |
ASX - By Stock
|
20
|
9.4K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Halucenex secures agreement with R&D partner Nucro-Technics
|
|
NBerardis
|
11 |
4.1K |
2 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
11
|
4.1K
|
2
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Halucenex secures agreement with R&D partner Nucro-Technics
|
|
NBerardis
|
11 |
4.1K |
0 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
11
|
4.1K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
0 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
88
|
25K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
0 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
88
|
25K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
0 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
88
|
25K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
0 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
88
|
25K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
1 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
88
|
25K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Halucenex secures agreement with R&D partner Nucro-Technics
|
|
NBerardis
|
11 |
4.1K |
4 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
11
|
4.1K
|
4
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Halucenex secures agreement with R&D partner Nucro-Technics
|
|
NBerardis
|
11 |
4.1K |
0 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
11
|
4.1K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Creso Pharma - A Global Cannabis and Psychedelics Powerhouse in the Making
|
|
NBerardis
|
374 |
116K |
1 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
374
|
116K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Creso Pharma - A Global Cannabis and Psychedelics Powerhouse in the Making
|
|
NBerardis
|
374 |
116K |
0 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
374
|
116K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
2021 CPH Discussion
|
|
NBerardis
|
114 |
38K |
1 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
114
|
38K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Creso Pharma (ASX:CPH) poised to lead US$100B medicinal psychedelics market
|
|
NBerardis
|
109 |
68K |
1 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
109
|
68K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
2 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
88
|
25K
|
2
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
1 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
88
|
25K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
1 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
88
|
25K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
3 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
88
|
25K
|
3
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
3 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
88
|
25K
|
3
|
|
ASX - By Stock
|
CPH |
Re:
Creso Pharma (ASX:CPH) poised to lead US$100B medicinal psychedelics market
|
|
NBerardis
|
109 |
68K |
1 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
109
|
68K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Creso Pharma - A Global Cannabis and Psychedelics Powerhouse in the Making
|
|
NBerardis
|
374 |
116K |
0 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
374
|
116K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Creso Pharma - A Global Cannabis and Psychedelics Powerhouse in the Making
|
|
NBerardis
|
374 |
116K |
0 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
374
|
116K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
0 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
88
|
25K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
0 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
88
|
25K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
1 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
88
|
25K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
3 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
88
|
25K
|
3
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
3 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
88
|
25K
|
3
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
0 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
88
|
25K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
0 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
88
|
25K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
0 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
88
|
25K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
1 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
88
|
25K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
2 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
88
|
25K
|
2
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
1 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
88
|
25K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
0 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
88
|
25K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
1 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
88
|
25K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
0 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
88
|
25K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
1 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
88
|
25K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
0 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
88
|
25K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
1 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
88
|
25K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
0 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
88
|
25K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
11 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
88
|
25K
|
11
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Quarterly Update & Appendix 4C
|
|
NBerardis
|
88 |
25K |
3 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
88
|
25K
|
3
|
|
ASX - By Stock
|
CPH |
Re:
2021 CPH Discussion
|
|
NBerardis
|
114 |
38K |
2 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
114
|
38K
|
2
|
|
ASX - By Stock
|
CPH |
Re:
2021 CPH Discussion
|
|
NBerardis
|
114 |
38K |
2 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
114
|
38K
|
2
|
|
ASX - By Stock
|
CPH |
Re:
2021 CPH Discussion
|
|
NBerardis
|
114 |
38K |
0 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
114
|
38K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
2021 CPH Discussion
|
|
NBerardis
|
114 |
38K |
7 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
114
|
38K
|
7
|
|